MGRX
Income statement / Annual
Last year (2024), Mangoceuticals, Inc.'s total revenue was $473,260.00,
a decrease of 35.30% from the previous year.
In 2024, Mangoceuticals, Inc.'s net income was -$8.71 M.
See Mangoceuticals, Inc.,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
| Period Ended |
12/31/2024 |
12/31/2023 |
12/31/2022 |
12/31/2021 |
| Operating Revenue |
$473,260.00 |
$731,493.00 |
$8,939.00 |
$0.00 |
| Cost of Revenue |
$235,909.00
|
$299,992.00
|
$4,089.00
|
$0.00
|
| Gross Profit |
$237,351.00
|
$431,501.00
|
$4,850.00
|
$0.00
|
| Gross Profit Ratio |
0.5
|
0.59
|
0.54
|
0
|
| Research and Development Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| General & Administrative Expenses |
$3.00 M
|
$6.45 M
|
$2.00 M
|
$70,080.00
|
| Selling & Marketing Expenses |
$1.48 M
|
$2.10 M
|
$352,860.00
|
-$52,560.00
|
| Selling, General & Administrative Expenses |
$4.48 M
|
$8.55 M
|
$2.00 M
|
$17,520.00
|
| Other Expenses |
$3.78 M
|
$1.10 M
|
$0.00
|
$0.00
|
| Operating Expenses |
$8.35 M
|
$9.65 M
|
$2.00 M
|
$17,520.00
|
| Cost And Expenses |
$8.35 M
|
$9.95 M
|
$2.00 M
|
$17,520.00
|
| Interest Income |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Interest Expense |
$13,700.00
|
$0.00
|
$6,473.00
|
$181.00
|
| Depreciation & Amortization |
$721,533.00
|
$24,889.00
|
$3,863.00
|
$70,080.00
|
| EBITDA |
-$7.97 M |
-$9.19 M |
-$1.99 M |
$52,560.00 |
| EBITDA Ratio |
-16.84
|
-12.56
|
-222.36
|
0
|
| Operating Income Ratio |
-16.84
|
-12.6
|
-222.8
|
0
|
| Total Other Income/Expenses Net |
-$735,233.00
|
$6,473.00
|
-$6,473.00
|
-$53,284.00
|
| Income Before Tax |
-$8.71 M
|
-$9.21 M
|
-$2.00 M
|
-$17,701.00
|
| Income Before Tax Ratio |
-18.4
|
-12.59
|
-223.52
|
0
|
| Income Tax Expense |
$0.00
|
$0.00
|
-$224,622.00
|
-$70,080.00
|
| Net Income |
-$8.71 M
|
-$9.21 M
|
-$2.00 M
|
-$17,701.00
|
| Net Income Ratio |
-18.4
|
-12.59
|
-223.52
|
0
|
| EPS |
-4.4 |
-8.58 |
-1.96 |
-10222.93 |
| EPS Diluted |
-4.4 |
-8.58 |
-1.96 |
-10222.93 |
| Weighted Average Shares Out |
$1.98 M
|
$1.07 M
|
$1.02 M
|
$1.73
|
| Weighted Average Shares Out Diluted |
$1.98 M
|
$1.07 M
|
$1.02 M
|
$1.73
|
| Link |
|
|
|
|
